http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AT-388500-B

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_571b8abacacea64d3f7089d0983b8b3b
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-52
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-52
filingDate 1987-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1989-06-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1989-06-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber AT-388500-B
titleOfInvention ANTIVIRAL 8-PHENYLXANTHINE
abstract The present invention relates to the use of certain 8- phenylxanthines which are substituted in position 4 of the phenyl group by an alkenylene having a terminal acidic group for the production of medicaments for human and veterinary therapy, in particular for antiviral, especially antiretroviral, chemotherapy.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9200742-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AP-291-A
priorityDate 1987-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0092398-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0203721-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410390849
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12295530
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811

Total number of triples: 18.